Cargando…

Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease

BACKGROUND: The EuroQoL 5D (EQ-5D) is a questionnaire that provides a measure of utility for cost-effectiveness analysis. The EQ-5D has been widely used in many patient groups, including those with coronary heart disease. Studies often require patients to complete many questionnaires and the EQ-5D m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldsmith, Kimberley A, Dyer, Matthew T, Buxton, Martin J, Sharples, Linda D
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900231/ https://www.ncbi.nlm.nih.gov/pubmed/20525323 http://dx.doi.org/10.1186/1477-7525-8-54

Ejemplares similares

Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions
por: Goldsmith, Kimberley A, et al.
Publicado: (2009)

A review of health utilities using the EQ-5D in studies of cardiovascular disease
por: Dyer, Matthew TD, et al.
Publicado: (2010)

Mapping the Seattle Angina Questionnaire to EQ-5D-5L in patients with coronary heart disease
por: Li, Chaofan, et al.
Publicado: (2023)

Mapping the Oxford Shoulder Score onto the EQ-5D utility index
por: Valsamis, Epaminondas M., et al.
Publicado: (2022)

Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
por: van Stel, Henk F, et al.
Publicado: (2006)

Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
por: Rowen, Donna, et al.
Publicado: (2009)

Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson’s disease
por: Dams, Judith, et al.
Publicado: (2013)

Mapping of the Insomnia Severity Index and other sleep measures to EuroQol EQ-5D health state utilities
por: Gu, Ning Yan, et al.
Publicado: (2011)

Mapping and direct valuation: do they give equivalent EQ-5D-5L index scores?
por: Luo, Nan, et al.
Publicado: (2015)

Mapping health assessment questionnaire disability index onto EQ-5D-5L in China
por: Wan, Chuchuan, et al.
Publicado: (2023)

The validation of published utility mapping algorithms: an example of EORTC QLQ-C30 and EQ-5D in non-small cell lung cancer
por: Gregory, Joanne, et al.
Publicado: (2020)

Mapping onto Eq-5 D for patients in poor health
por: Versteegh, Matthijs M, et al.
Publicado: (2010)

Mapping the Minnesota living with heart failure questionnaire (MLHFQ) to EQ-5D-5L in patients with heart failure
por: Kularatna, Sanjeewa, et al.
Publicado: (2020)

Mapping the EQ-5D index from the cystic fibrosis questionnaire-revised using multiple modelling approaches
por: Acaster, Sarah, et al.
Publicado: (2015)

Mapping health outcome measures from a stroke registry to EQ-5D weights
por: Ghatnekar, Ola, et al.
Publicado: (2013)

Clinical and cost-effectiveness analysis of an open label, single-centre, randomised trial of spinal cord stimulation (SCS) versus percutaneous myocardial laser revascularisation (PMR) in patients with refractory angina pectoris: The SPiRiT trial
por: Dyer, M T, et al.
Publicado: (2008)

Mapping the Insomnia Severity Index Instrument to EQ-5D Health State Utilities: A United Kingdom Perspective
por: Chalet, François-Xavier, et al.
Publicado: (2023)

Mapping EORTC-QLQ-C30 onto EQ-5D-5L Index in Indonesian Cancer Patients
por: Perwitasari, Dyah Aryani, et al.
Publicado: (2023)

Modelling the relationship between the WOMAC osteoarthritis index and EQ-5D
por: Wailoo, Allan, et al.
Publicado: (2014)

Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database
por: Dakin, Helen
Publicado: (2013)

Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients
por: Pattanaphesaj, Juntana, et al.
Publicado: (2015)

The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa
por: Bató, Alex, et al.
Publicado: (2021)

Level of agreement between patient-reported EQ-5D responses and EQ-5D responses mapped from the SF-12 in an injury population
por: Gabbe, Belinda J, et al.
Publicado: (2015)

Mapping From Visual Acuity to EQ-5D, EQ-5D With Vision Bolt-On, and VFQ-UI in Patients With Macular Edema in the LEAVO Trial
por: Pennington, Becky M., et al.
Publicado: (2020)

Mapping between EQ‐5D‐3L and EQ‐5D‐5L: A survey experiment on the validity of multi‐instrument data
por: Hernández‐Alava, Mónica, et al.
Publicado: (2022)

Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients
por: Golicki, Dominik, et al.
Publicado: (2014)

Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer
por: Hagiwara, Yasuhiro, et al.
Publicado: (2020)

Mapping of disease-specific Oxford Knee Score onto EQ-5D-5L utility index in knee osteoarthritis
por: Fawaz, Hadeer, et al.
Publicado: (2023)

Cost-effectiveness of initial stress cardiovascular MR, stress SPECT or stress echocardiography as a gate-keeper test, compared with upfront invasive coronary angiography in the investigation and management of patients with stable chest pain: mid-term outcomes from the CECaT randomised controlled trial
por: Thom, Howard, et al.
Publicado: (2014)

Measuring quality of life in opioid-induced constipation: mapping EQ-5D-3 L and PAC-QOL
por: Hatswell, Anthony James, et al.
Publicado: (2016)

Mapping the Patient-Reported Outcomes Measurement Information System (PROMIS-29) to EQ-5D-5L
por: Aghdaee, Mona, et al.
Publicado: (2022)

Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients
por: Fitriana, Titi Sahidah, et al.
Publicado: (2021)

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
por: Shiroiwa, Takeru, et al.
Publicado: (2015)

Mapping the EORTC QLQ-C30 onto the EQ-5D-5L index for patients with paroxysmal nocturnal hemoglobinuria in France
por: Wojciechowski, Piotr, et al.
Publicado: (2023)

Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments
por: Wolfs, Claire AG, et al.
Publicado: (2007)

Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
por: Wille, Nora, et al.
Publicado: (2010)

Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement
por: Dakin, Helen, et al.
Publicado: (2018)

Health-Related Utility of EQ-5D in Korean Adults With Chronic Urticaria: Mapping From Urticaria Outcome Measures
por: Lee, Min-Sang, et al.
Publicado: (2020)

A comparison of the responsiveness of EQ-5D-5L and the QOLIE-31P and mapping of QOLIE-31P to EQ-5D-5L in epilepsy
por: Wijnen, Ben F. M., et al.
Publicado: (2017)

Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy
por: Bhadhuri, Arjun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_58nmvtrqbm5ke5iu6041n4anl4